Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marksans Pharma Ltd. Board/Management Information 2019

Mar 22, 2019

62142_rns_2019-03-22_400f799c-45aa-4e5b-924b-e73b9069a33c.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

.-.

Marksans Pharma Ltd.

To,

National Stock Exchange of India Limited

Exchange Plaza C-1, Block tG'Bandra Kurla Complex Bandra (E), Mumbai - 400051 Scrip Code: MARKSANS

To,

BSELimited Phiroze Jeejeebhoy Towers Dalal Street, Fort Mumbai - 400001 Scrip Code: 524404

Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015 t[please][be][informed] that due to personal reasont Mr. st Ajay Shivram Joshi (DIN: 00947684) has resigned as Director of the Company effective from 1 April, 2019.

You are requested to note the above in your records.

Thanking You. Yours faithfully, For Marksans Pharma Limited

~ !?(?r)MJ

Harsha~~:n Panigrahi Company Secretary & Manager-Legal

Marksans Pharma Ltd.

11th FI.o0r,"GRAND,EUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andhen (W), Mumbal - 400053 • Tel.: +91 224001 2000 • E-mail: [email protected]www.marksanspharma.com